佰仁醫療(688198.SH)業績快報:2020年度淨利升37.25%至8658.37萬元(經調)
格隆匯1月29日丨佰仁醫療(688198.SH)披露2020年度業績快報,2020年度,公司實現營業收入1.82億元,同比增長24.58%;實現歸屬於母公司所有者淨利潤5602.09萬元,同比下降11.20%;剔除股份支付費用後經調整的歸屬於母公司所有者淨利潤8658.37萬元,同比增加37.25%;歸屬於母公司所有者的扣除非經常性損益的淨利潤4063.90萬元,同比下降30.98%;基本每股收益0.58元。
報吿期內,新冠肺炎疫情給公司業務帶來種種困難,但公司在全體員工的努力下依然完成了預期銷售目標,全年營業收入實現同比增長24.58%。分季度來看,公司一季度營業收入同比下降24.68%,二季度開始逆勢增長,三、四季度強勢上升,分別實現了同比增長14.6%、39.26%、59.37%。公司三個業務板塊收入均實現同比增長,其中心臟瓣膜置換與修復板塊呈現收入加速增長趨勢,同比增長約130%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.